ARCHIVES

In Brief: Lepovetsky Heads New NCI Office Of Technology Development; Temporary Now, Maybe Permanent

This article is from The Cancer Letter archive.

Vol. 13 No. 46 | November 27, 1987

Download PDF Visit The Full Archive

Related Articles

Xeloda + Oxaliplatin Compares To FOLFOX-4 In First Line

January 30, 2009

FDA Approves Abbott’s HER-2 DNA Probe Kit.

January 25, 2002

H. Lee Moffitt Center Reads The Cancer Letter

July 19, 2002

The March: Research Task Force Calls For $10 Billion NCI Budget In 5 Years

October 2, 1998

HEW To Pay All Care Cost At 26 Hospices

January 11, 1980

UC Davis Study Finds Patients Need Practical Information

June 28, 2002